IP Library Granted Patent US 12,685,851
Granted Patent B2
US 12,685,851 · App. 17/380,415 · Granted Jul 21, 2026

Fluid catheter device for recording brain state

Inventors: Daniel J. Abrams (Denver, CO); Matias Maturana (Melbourne, AU)
Assignee: Biogen MA Inc.
A61M27/006A61B5/293A61B5/6852A61B5/6864A61B5/6868A61M25/0026A61M39/0247A61M2039/0273A61M2039/0276
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,685,851
App. No.
17/380,415
Filed
Jul 20, 2021
Granted
Jul 21, 2026
Kind
B2
Art Unit
3781
USPC
604/8
Abstract

A device or system for delivering fluid to or removing fluid from a CSF-containing space of a brain and for recording electrical activity from white or grey matter in the brain includes a catheter including a proximal end, a distal end portion, a first lumen extending from the proximal end to the distal end portion, and one or more electrodes positioned relative to the catheter a distance from a distal end of the catheter, such that the one or more electrodes would be placed in contact with white or grey matter of the brain if the distal end of the catheter were positioned in the CSF-containing space. The catheter may include the electrodes or a lead adjacent the catheter may include the electrodes.

Claims (50)

1 . A device or system for delivering fluid to or removing fluid from a cerebrospinal fluid (CSF)-containing space of a brain and for recording electrical brain state activity from white or grey matter in the brain, the device or system comprising:

a CSF catheter comprising a proximal end, a distal end portion, and a first lumen extending from the proximal end to the distal end portion; and

a brain lead extending from and coupled to the CSF catheter by a snap fit connector comprising at least one deflectable element configured to resiliently deflect as at least one of the brain lead or the CSF catheter is inserted, the brain lead comprising an electrode positioned a distance from the distal end of the CSF catheter such that the electrode is configured to contact white or grey matter of the brain when the distal end of the CSF catheter is placed in the CSF-containing space;

signal processing electronics configured to operably couple to the brain lead and to record electrical activity detected by the electrode and to determine a brain state or to predict a future brain state; and

an external apparatus configured to wirelessly receive signals associated with the recorded electrical activity from the signal processing electronics.

2 . The device or system of claim 1 , wherein the CSF-containing space is a lateral ventricle.

3 . The device or system of claim 2 , wherein the electrode is positioned a distance from about 0.5 centimeters to about 6 centimeters to the distal end of the CSF catheter.

4 . The device or system of claim 2 , wherein the electrode is positioned a distance from about 1 centimeter to about 5 centimeters to the distal end of the CSF catheter.

5 . The device or system of claim 2 , wherein the electrode is positioned a distance from about 2 centimeters to about 6 centimeters to the distal end of the CSF catheter.

6 . The device or system of claim 1 , wherein the brain lead is coupled relative to the CSF catheter at the distal end portion of the CSF catheter.

7 . The device or system of claim 1 , wherein the brain lead is secured to the CSF catheter along a substantial length of the CSF catheter.

8 . The device or system of claim 1 , comprising a brain signal electrical interconnect, wherein the brain signal electrical interconnect comprises a contact electrically coupled to the electrode through the brain lead.

9 . The device or system of claim 8 , wherein the CSF catheter comprises the brain signal electrical interconnect.

10 . The device or system of claim 8 , wherein the brain lead comprises the brain signal electrical interconnect.

11 . The device or system of claim 8 , wherein the brain signal electrical interconnect is physically separate from the brain lead.

12 . The device or system of claim 11 , further comprising a cable extending from the brain lead to the brain signal electrical interconnect, wherein the cable comprises a conductor electrically connecting the electrode to the contact.

13 . The device or system of claim 1 , further comprising an access port having a first fluid flow path in communication with the first lumen of the CSF catheter or having a connector configured to secure the CSF catheter such that first lumen is in communication with the first fluid flow path.

14 . The device or system of claim 13 , wherein the access port is configured to be implanted below a scalp.

15 . The device or system of claim 14 , wherein at least a portion of the access port is configured to be implanted over a burr hole.

16 . The device or system of claim 14 , wherein at least a portion of the access port is configured to be implanted in a burr hole.

17 . The device or system of claim 1 , further comprising an implantable infusion device, wherein the implantable infusion device comprises at least a portion of the signal processing electronics.

18 . The device or system of claim 1 , wherein the cranial catheter is an external ventricular drainage catheter or a ventriculoperitoneal shunt.

19 . The device or system of claim 1 , wherein the signal processing electronics are further configured to apply brain stimulative electrical signals to a stimulating electrode coupled to the CSF catheter.

20 . The device or system of claim 1 , wherein the signal processing electronics are further configured to wirelessly transmit the signals to the external apparatus through a portion of a scalp.

21 . The device or system of claim 1 , wherein the external apparatus is further configured to wirelessly power the signal processing electronics using inductive coupling.

22 . The device or system of claim 1 , wherein the brain lead is coupled to the CSF catheter by a snap fit connector comprising a first opening and a second opening.

23 . The device or system of claim 22 , wherein the second opening is symmetrical to the first opening.

24 . The device or system of claim 22 , wherein the first opening is configured to engage the brain lead and the second opening is configured to engage the CSF catheter.

25 . The device or system of claim 1 , wherein the brain lead is coupled to the CSF catheter by a sleeve.

26 . The device or system of claim 1 , wherein the snap fit connector comprises a first set of deflectable elements and a second set of deflectable elements.

27 . The device or system of claim 26 , wherein the first set of deflectable elements is configured to engage the brain lead and the second set of deflectable elements is configured to engage the CSF catheter.

28 . A device or system comprising:

an implantable access port, the access port comprising:

an opening accessible by a needle when the access port is implanted;

a first catheter connector;

a second catheter connector;

a first fluid flow path extending from the opening to the first catheter connector; and

a second fluid flow path extending from the second catheter connector to the first catheter connector;

a CSF catheter coupled to, or operably couplable to, the first catheter connector, the CSF catheter comprising a proximal end, a distal end portion, and first and second lumens extending from the proximal end to the distal portion of the CSF catheter;

a brain lead extending from and coupled to the CSF catheter by a snap fit connector comprising at least one deflectable element configured to resiliently deflect as at least one of the brain lead or the CSF catheter is inserted, the brain lead comprising an electrode configured to detect electrical activity determinative of a brain state or predictive of a future brain state,

wherein the first lumen is in communication with the first fluid flow path and the second lumen is in communication with the second fluid flow path when the proximal end of the CSF catheter is coupled to the first catheter connector,

wherein the CSF catheter has a length such that a distal end is configured to extend to a CSF-containing space of a subject when the access port is implanted,

wherein the electrode is positioned a distance from the distal end of the CSF catheter and configured to be positioned in white or grey matter of a brain of the subject when the access port is implanted and the distal end of the CSF catheter is positioned in the CSF-containing space;

signal processing electronics configured to operably couple to the brain lead and to record electrical activity detected by the electrode and to determine a brain state or to predict a future brain state; and

an external apparatus configured to wirelessly receive signals associated with the recorded electrical activity from the signal processing electronics.

29 . The device or system of claim 28 , wherein the signal processing electronics are further configured to apply brain stimulative electrical signals to a stimulating electrode coupled to the CSF catheter.

30 . The device or system of claim 29 , wherein the stimulating electrode is the brain lead electrode.

31 . The device or system of claim 28 , wherein the second fluid flow path comprises a microbial filter.

32 . The device or system of claim 28 , wherein the signal processing electronics are further configured to wirelessly transmit the signals to the external apparatus through a portion of a scalp of the subject.

33 . The device or system of claim 28 , wherein the external apparatus is further configured to wirelessly power the signal processing electronics using inductive coupling.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 1, 2024
From: CEREBRAL THERAPEUTICS, INC.
To: BIOGEN MA INC.
Reel/Frame 069104/0201 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 2, 2022
From: ABRAMS, DANIEL J.; MATURANA, MATIAS I.
To: CEREBRAL THERAPEUTICS, INC.
Reel/Frame 060091/0090 →
Continuity (2)
Provisional Application 63053864 · Jul 20, 2020
Related Publication 20220016404A1 · Jan 20, 2022
References Cited (400)
US 1456469A · Schwidetzky · 1923 [cited by applicant]
US 2609818A · Parrine · 1952 [cited by applicant]
US 3040743A · Knut · 1962 [cited by applicant]
US 3506006A · Lange, Jr. · 1970 [cited by applicant]
US 3563373A · Paulson · 1971 [cited by applicant]
US 3640269A · Delgado · 1972 [cited by applicant]
US 3888249A · Spencer · 1975 [cited by applicant]
US 3892237A · Steiner · 1975 [cited by applicant]
US 4281666A · Cosman · 1981 [cited by examiner]
US 4281667A · Cosman · 1981 [cited by examiner]
US 4464168A · Redmond et al. · 1984 [cited by applicant]
US 4500311A · Redmond et al. · 1985 [cited by applicant]
US 4583968A · Mahurkar · 1986 [cited by applicant]
US 4677985A · Bro et al. · 1987 [cited by applicant]
US 4723556A · Sussman · 1988 [cited by applicant]
US 4732850A · Brown et al. · 1988 [cited by applicant]
US 4767410A · Moden et al. · 1988 [cited by applicant]
US 4779763A · Klawitter · 1988 [cited by applicant]
US 4861335A · Reynolds · 1989 [cited by applicant]
US 4883101A · Strong · 1989 [cited by applicant]
US 4904241A · Bark · 1990 [cited by applicant]
US 4946778A · Ladner et al. · 1990 [cited by applicant]
US 4958622A · Selenke · 1990 [cited by applicant]
US 5067948A · Haber et al. · 1991 [cited by applicant]
US 5197951A · Mahurkar · 1993 [cited by applicant]
US 5225539A · Winter · 1993 [cited by applicant]
US 5334163A · Sinnett · 1994 [cited by applicant]
US 5377864A · Blechl et al. · 1995 [cited by applicant]
US 5522807A · Luther · 1996 [cited by applicant]
US 5648237A · Carter · 1997 [cited by applicant]
US 5704352A · Tremblay · 1998 [cited by examiner]
US 5720720A · Laske et al. · 1998 [cited by applicant]
US 5736137A · Anderson et al. · 1998 [cited by applicant]
US 5810789A · Powers et al. · 1998 [cited by applicant]
US 5823961A · Fields et al. · 1998 [cited by applicant]
US 5897528A · Schultz · 1999 [cited by applicant]
US 5902331A · Bonner · 1999 [cited by examiner]
US 6001806A · Hilbert et al. · 1999 [cited by applicant]
US 6006124A · Fischell et al. · 1999 [cited by applicant]
US 6013051A · Nelson · 2000 [cited by applicant]
US 6018036A · Mosmann et al. · 2000 [cited by applicant]
US 6086555A · Eliasen · 2000 [cited by examiner]
US 6113578A · Brown · 2000 [cited by applicant]
US 6248080B1 · Miesel · 2001 [cited by examiner]
US 6248126B1 · Lesser · 2001 [cited by examiner]
US 6293922B1 · Haase · 2001 [cited by applicant]
US 6324433B1 · Errico · 2001 [cited by applicant]
US 6451977B1 · de Sauvage et al. · 2002 [cited by applicant]
US 6458943B1 · Byrne · 2002 [cited by applicant]
US 6475987B1 · Shu · 2002 [cited by applicant]
US 6482185B1 · Hartmann · 2002 [cited by applicant]
US 6562023B1 · Marrs · 2003 [cited by examiner]
US 6573099B2 · Graham · 2003 [cited by applicant]
US 6595979B1 · Epstein et al. · 2003 [cited by applicant]
US 6632927B2 · Adair et al. · 2003 [cited by applicant]
US 6720138B2 · Sharma et al. · 2004 [cited by applicant]
US 6753139B1 · Baulcombe et al. · 2004 [cited by applicant]
US 7056704B2 · Tuschl et al. · 2006 [cited by applicant]
US 7083785B2 · Browning et al. · 2006 [cited by applicant]
US 7112421B2 · Ambrose et al. · 2006 [cited by applicant]
US 7161488B2 · Frasch · 2007 [cited by applicant]
US 7195616B2 · Diller et al. · 2007 [cited by applicant]
US 7359765B2 · Varvarelis et al. · 2008 [cited by applicant]
US 7371388B1 · Ruben et al. · 2008 [cited by applicant]
US 7618409B2 · Hochman · 2009 [cited by applicant]
US 7670327B2 · Kucharczyk et al. · 2010 [cited by applicant]
US 7883502B2 · Powers et al. · 2011 [cited by applicant]
US 7917222B1 · Osorio · 2011 [cited by examiner]
US 7922695B2 · Wiegel et al. · 2011 [cited by applicant]
US 8066681B1 · Hall et al. · 2011 [cited by applicant]
US 8277425B2 · Girard et al. · 2012 [cited by applicant]
US 8409133B2 · Pesach et al. · 2013 [cited by applicant]
US 8543222B1 · Sochor · 2013 [cited by examiner]
US 8556866B2 · Krulevitch et al. · 2013 [cited by applicant]
US 8744544B2 · Najafi et al. · 2014 [cited by applicant]
US 8808234B2 · Vogelbaum et al. · 2014 [cited by applicant]
US 8827964B2 · Boyd et al. · 2014 [cited by applicant]
US 8979822B2 · Vogelbaum et al. · 2015 [cited by applicant]
US 9913960B2 · Blanchard et al. · 2018 [cited by applicant]
US 10506988B2 · Karoly et al. · 2019 [cited by applicant]
US 10716921B2 · Purdy · 2020 [cited by applicant]
US 10967172B1 · Shire et al. · 2021 [cited by applicant]
US 11504516B2 · Otto · 2022 [cited by applicant]
US 11534592B2 · Singh et al. · 2022 [cited by applicant]
US 12097029B1 · Shanechi · 2024 [cited by applicant]
US 20020004643A1 · Carmel et al. · 2002 [cited by applicant]
US 20020052563A1 · Penn · 2002 [cited by examiner]
US 20020086356A1 · Tuschl et al. · 2002 [cited by applicant]
US 20030012783A1 · Kindsvogel · 2003 [cited by applicant]
US 20030069623A1 · Stypulkowski · 2003 [cited by examiner]
US 20030097051A1 · Kolberg · 2003 [cited by examiner]
US 20030097082A1 · Purdy · 2003 [cited by examiner]
US 20030108923A1 · Tuschl et al. · 2003 [cited by applicant]
US 20030135148A1 · Dextradeur et al. · 2003 [cited by applicant]
US 20030204075A9 · Wang · 2003 [cited by applicant]
US 20030216714A1 · Gill · 2003 [cited by applicant]
US 20030228691A1 · Lewis et al. · 2003 [cited by applicant]
US 20040002677A1 · Gentsler · 2004 [cited by applicant]
US 20040053411A1 · Cullen et al. · 2004 [cited by applicant]
US 20040069044A1 · Lavi et al. · 2004 [cited by applicant]
US 20040073196A1 · Adams et al. · 2004 [cited by applicant]
US 20040082984A1 · Osorio · 2004 [cited by examiner]
US 20040086884A1 · Beach et al. · 2004 [cited by applicant]
US 20040102412A1 · Broschat et al. · 2004 [cited by applicant]
US 20040106566A1 · Lin et al. · 2004 [cited by applicant]
US 20040112411A1 · Boykin et al. · 2004 [cited by applicant]
US 20040152112A1 · Croce et al. · 2004 [cited by applicant]
US 20040171037A1 · Li et al. · 2004 [cited by applicant]
US 20040171983A1 · Sparks et al. · 2004 [cited by applicant]
US 20040175732A1 · Rana · 2004 [cited by applicant]
US 20040210951A1 · Baulcombe et al. · 2004 [cited by applicant]
US 20040215162A1 · Putz · 2004 [cited by applicant]
US 20040221337A1 · Baulcombe et al. · 2004 [cited by applicant]
US 20040229266A1 · Tuschl et al. · 2004 [cited by applicant]
US 20040253604A1 · Lin et al. · 2004 [cited by applicant]
US 20040259247A1 · Tuschl et al. · 2004 [cited by applicant]
US 20040259248A1 · Tuschl et al. · 2004 [cited by applicant]
US 20040268441A1 · Vance et al. · 2004 [cited by applicant]
US 20050004219A1 · Hildebrand et al. · 2005 [cited by applicant]
US 20050004639A1 · Erickson · 2005 [cited by examiner]
US 20050026278A1 · Tuschl et al. · 2005 [cited by applicant]
US 20050037988A1 · Zamore et al. · 2005 [cited by applicant]
US 20050038371A1 · Reich et al. · 2005 [cited by applicant]
US 20050059005A1 · Tuschl et al. · 2005 [cited by applicant]
US 20050059011A1 · Sin et al. · 2005 [cited by applicant]
US 20050070458A1 · John · 2005 [cited by applicant]
US 20050074788A1 · Dahlberg et al. · 2005 [cited by applicant]
US 20050075492A1 · Chen et al. · 2005 [cited by applicant]
US 20050079614A1 · Reinhart et al. · 2005 [cited by applicant]
US 20050137578A1 · Heruth et al. · 2005 [cited by applicant]
US 20050159697A1 · Dextradeur · 2005 [cited by examiner]
US 20050163775A1 · Chan et al. · 2005 [cited by applicant]
US 20050209332A1 · Kuppuswamy et al. · 2005 [cited by applicant]
US 20050228315A1 · Ayad · 2005 [cited by examiner]
US 20050245906A1 · Makower et al. · 2005 [cited by applicant]
US 20060004317A1 · Mauge · 2006 [cited by examiner]
US 20060067933A1 · Gross et al. · 2006 [cited by applicant]
US 20060073146A1 · Ashkenazi et al. · 2006 [cited by applicant]
US 20060079834A1 · Tennican et al. · 2006 [cited by applicant]
US 20060084055A1 · Gaiger et al. · 2006 [cited by applicant]
US 20060084929A1 · Eliasen · 2006 [cited by applicant]
US 20060122677A1 · Vardiman · 2006 [cited by examiner]
US 20060160889A1 · Veeneman et al. · 2006 [cited by applicant]
US 20060286093A1 · Gross et al. · 2006 [cited by applicant]
US 20070073228A1 · Mernoe et al. · 2007 [cited by applicant]
US 20070078438A1 · Okada · 2007 [cited by applicant]
US 20070083063A1 · Nelson et al. · 2007 [cited by applicant]
US 20070086979A1 · Chevrier et al. · 2007 [cited by applicant]
US 20070123758A1 · Miesel et al. · 2007 [cited by applicant]
US 20070185017A1 · Aggarwal et al. · 2007 [cited by applicant]
US 20070197957A1 · Hunter et al. · 2007 [cited by applicant]
US 20070255237A1 · Lobl et al. · 2007 [cited by applicant]
US 20070260375A1 · Hilton · 2007 [cited by applicant]
US 20080027346A1 · Litt et al. · 2008 [cited by applicant]
US 20080039774A1 · Zawacki et al. · 2008 [cited by applicant]
US 20080058476A1 · Whiteker et al. · 2008 [cited by applicant]
US 20080132980A1 · Gerber · 2008 [cited by examiner]
US 20080132981A1 · Gerber · 2008 [cited by examiner]
US 20080147006A1 · Brunnberg et al. · 2008 [cited by applicant]
US 20080262374A1 · Gerber et al. · 2008 [cited by applicant]
US 20090030480A1 · Durand et al. · 2009 [cited by applicant]
US 20090069267A1 · Abrams et al. · 2009 [cited by applicant]
US 20090069742A1 · Larsen · 2009 [cited by applicant]
US 20090112327A1 · Lane et al. · 2009 [cited by applicant]
US 20090131850A1 · Geiger · 2009 [cited by applicant]
US 20090131857A1 · Geiger · 2009 [cited by applicant]
US 20090137944A1 · Haarala et al. · 2009 [cited by applicant]
US 20090203983A1 · Carlton et al. · 2009 [cited by applicant]
US 20090228066A1 · Hirata et al. · 2009 [cited by applicant]
US 20100036477A1 · Bronson · 2010 [cited by examiner]
US 20100089167A1 · Trieu et al. · 2010 [cited by applicant]
US 20100145162A1 · Devauchelle · 2010 [cited by examiner]
US 20100145176A1 · Himes · 2010 [cited by applicant]
US 20100158869A1 · Kaemmerer · 2010 [cited by applicant]
US 20100168532A1 · Waziri et al. · 2010 [cited by applicant]
US 20100210958A1 · Manwaring · 2010 [cited by examiner]
US 20100241088A1 · Ranalletta et al. · 2010 [cited by applicant]
US 20100280335A1 · Carlson et al. · 2010 [cited by applicant]
US 20100286585A1 · DiMauro · 2010 [cited by examiner]
US 20100305492A1 · Lad et al. · 2010 [cited by applicant]
US 20110009821A1 · Jespersen et al. · 2011 [cited by applicant]
US 20110009933A1 · Barker · 2011 [cited by examiner]
US 20110033463A1 · Thakker et al. · 2011 [cited by applicant]
US 20110066072A1 · Kawoos et al. · 2011 [cited by applicant]
US 20110092921A1 · Beling et al. · 2011 [cited by applicant]
US 20110172633A1 · Ali et al. · 2011 [cited by applicant]
US 20110201944A1 · Higgins et al. · 2011 [cited by applicant]
US 20110257596A1 · Gaudet · 2011 [cited by applicant]
US 20110264033A1 · Jensen et al. · 2011 [cited by applicant]
US 20110270095A1 · Bukhman · 2011 [cited by examiner]
US 20110270230A1 · Sage et al. · 2011 [cited by applicant]
US 20110275930A1 · Jho et al. · 2011 [cited by applicant]
US 20120015336A1 · Mach · 2012 [cited by applicant]
US 20120087869A1 · Thakker et al. · 2012 [cited by applicant]
US 20120245529A1 · Hummen et al. · 2012 [cited by applicant]
US 20120290225A1 · Julian et al. · 2012 [cited by applicant]
US 20120296271A1 · Yomtov · 2012 [cited by examiner]
US 20120296404A1 · Carpentier · 2012 [cited by examiner]
US 20120302959A1 · Fielder · 2012 [cited by examiner]
US 20120310140A1 · Kramer et al. · 2012 [cited by applicant]
US 20130204229A1 · Olson et al. · 2013 [cited by applicant]
US 20130253266A1 · Dextradeur et al. · 2013 [cited by applicant]
US 20130267928A1 · Imran et al. · 2013 [cited by applicant]
US 20130324945A1 · Sabin · 2013 [cited by examiner]
US 20140012209A1 · Sansoucy · 2014 [cited by applicant]
US 20140074060A1 · Imran · 2014 [cited by applicant]
US 20140081347A1 · Nelson et al. · 2014 [cited by applicant]
US 20140148780A1 · Putz · 2014 [cited by examiner]
US 20140194825A1 · Nielsen et al. · 2014 [cited by applicant]
US 20140207074A1 · Nielsen · 2014 [cited by applicant]
US 20140236259A1 · Colantonio · 2014 [cited by examiner]
US 20140249410A1 · Uber, III et al. · 2014 [cited by applicant]
US 20140257168A1 · Gill · 2014 [cited by applicant]
US 20140276416A1 · Nelson · 2014 [cited by examiner]
US 20140276473A1 · Beling et al. · 2014 [cited by applicant]
US 20150038901A1 · Lampropoulos et al. · 2015 [cited by applicant]
US 20150202373A1 · Creaturo · 2015 [cited by applicant]
US 20150209505A1 · Hanson et al. · 2015 [cited by applicant]
US 20150230724A1 · Waziri et al. · 2015 [cited by applicant]
US 20150238685A1 · Elias et al. · 2015 [cited by applicant]
US 20150297874A1 · East et al. · 2015 [cited by applicant]
US 20150306302A1 · Marsden et al. · 2015 [cited by applicant]
US 20150367067A1 · Minaie et al. · 2015 [cited by applicant]
US 20160122282A1 · Kandula · 2016 [cited by applicant]
US 20160213312A1 · Singh et al. · 2016 [cited by applicant]
US 20160374901A9 · Rodriguez et al. · 2016 [cited by applicant]
US 20170007621A1 · Wotton et al. · 2017 [cited by applicant]
US 20170173267A1 · Ashmead et al. · 2017 [cited by applicant]
US 20170325685A1 · Shachar et al. · 2017 [cited by applicant]
US 20170365101A1 · Samec et al. · 2017 [cited by applicant]
US 20180028746A1 · Abrams et al. · 2018 [cited by applicant]
US 20180028824A1 · Pivonka et al. · 2018 [cited by applicant]
US 20180104459A1 · Anand et al. · 2018 [cited by applicant]
US 20180107798A1 · Hu · 2018 [cited by applicant]
US 20180107998A1 · Pederson · 2018 [cited by applicant]
US 20180140810A1 · Cataltepe · 2018 [cited by applicant]
US 20180193562A1 · Gibson et al. · 2018 [cited by applicant]
US 20180256892A1 · Wong · 2018 [cited by examiner]
US 20180263752A1 · Pinchuk et al. · 2018 [cited by applicant]
US 20190030322A1 · Schulte et al. · 2019 [cited by applicant]
US 20190082990A1 · Poltorak · 2019 [cited by applicant]
US 20190105019A1 · Pagoulatos et al. · 2019 [cited by applicant]
US 20190151239A1 · Abrams · 2019 [cited by examiner]
US 20190167964A1 · Lewis · 2019 [cited by examiner]
US 20190218334A1 · Delaney, Jr. et al. · 2019 [cited by applicant]
US 20190246989A1 · Genov et al. · 2019 [cited by applicant]
US 20190282802A1 · Malinowski · 2019 [cited by applicant]
US 20190321106A1 · Bergman et al. · 2019 [cited by applicant]
US 20190351209A1 · Butziger et al. · 2019 [cited by applicant]
US 20200061337A1 · Singh et al. · 2020 [cited by applicant]
US 20200069254A1 · Lange · 2020 [cited by examiner]
US 20200086538A1 · Funaoka · 2020 [cited by applicant]
US 20200170542A1 · Waziri · 2020 [cited by examiner]
US 20200338325A1 · Shachar et al. · 2020 [cited by applicant]
US 20200375492A1 · Govari · 2020 [cited by examiner]
US 20210077714A1 · Bodner · 2021 [cited by applicant]
US 20210100990A1 · Yoo et al. · 2021 [cited by applicant]
US 20210205623A1 · Peterson et al. · 2021 [cited by applicant]
US 20210252266A1 · Otto · 2021 [cited by examiner]
US 20210260280A1 · Gordon et al. · 2021 [cited by applicant]
US 20210327029A1 · Chen et al. · 2021 [cited by applicant]
US 20210338992A1 · Bertrand · 2021 [cited by applicant]
US 20210386982A1 · Lad et al. · 2021 [cited by applicant]
US 20210397970A1 · Cherian et al. · 2021 [cited by applicant]
US 20220016338A1 · Abrams et al. · 2022 [cited by applicant]
US 20220016402A1 · Abrams et al. · 2022 [cited by applicant]
US 20220016404A1 · Abrams et al. · 2022 [cited by applicant]
US 20220022800A1 · Abrams et al. · 2022 [cited by applicant]
US 20220249190A1 · Kelly et al. · 2022 [cited by applicant]
US 20220331567A1 · Abrams · 2022 [cited by applicant]
US 20230148923A1 · Abrams et al. · 2023 [cited by applicant]
US 20230200707A1 · Abrams et al. · 2023 [cited by applicant]
US 20230277840A1 · Abrams et al. · 2023 [cited by applicant]
US 20240021313A1 · Alkaitis et al. · 2024 [cited by applicant]
CA 3098311A1 · 2019 [cited by applicant]
DE 3127882A1 · 1983 [cited by applicant]
DE 102013002763A1 · 2014 [cited by applicant]
EP 0904119A1 · 1999 [cited by applicant]
EP 0995460A2 · 2000 [cited by applicant]
EP 1281758A2 · 2003 [cited by applicant]
EP 1391219A2 · 2004 [cited by applicant]
EP 1391219A3 · 2004 [cited by applicant]
EP 1798243A2 · 2007 [cited by applicant]
EP 3028727A1 · 2016 [cited by applicant]
JP 2004533997A · 2004 [cited by applicant]
JP 2007309746A · 2007 [cited by applicant]
KR 102054445B1 · 2019 [cited by applicant]
WO 9406690A1 · 1994 [cited by applicant]
WO 9427587A2 · 1994 [cited by applicant]
WO 96033761A1 · 1996 [cited by applicant]
WO 0040716A2 · 2000 [cited by applicant]
WO 0068378A1 · 2000 [cited by applicant]
WO 0160397A1 · 2001 [cited by applicant]
WO 0168836A2 · 2001 [cited by applicant]
WO 0175164A2 · 2001 [cited by applicant]
WO 0244321A2 · 2002 [cited by applicant]
WO 02066516A2 · 2002 [cited by applicant]
WO 02094185A2 · 2002 [cited by applicant]
WO 03013582A1 · 2003 [cited by applicant]
WO 03029459A2 · 2003 [cited by applicant]
WO 03062401A2 · 2003 [cited by applicant]
WO 03070884A2 · 2003 [cited by applicant]
WO 03070903A2 · 2003 [cited by applicant]
WO 03070918A2 · 2003 [cited by applicant]
WO 03072713A2 · 2003 [cited by applicant]
WO 03074566A2 · 2003 [cited by applicant]
WO 03074654A2 · 2003 [cited by applicant]
WO 2004009779A2 · 2004 [cited by applicant]
WO 2004031412A2 · 2004 [cited by applicant]
WO 2004039956A2 · 2004 [cited by applicant]
WO 2004057017A2 · 2004 [cited by applicant]
WO 2004066183A2 · 2004 [cited by applicant]
WO 2004072248A2 · 2004 [cited by applicant]
WO 2004111191A2 · 2004 [cited by applicant]
WO 2004112411A1 · 2004 [cited by applicant]
WO 2005000351A2 · 2005 [cited by applicant]
WO 2005012523A1 · 2005 [cited by applicant]
WO 2005017111A2 · 2005 [cited by applicant]
WO 2005019453A2 · 2005 [cited by applicant]
WO 2005023200A2 · 2005 [cited by applicant]
WO 2005023986A2 · 2005 [cited by applicant]
WO 2005033271A2 · 2005 [cited by applicant]
WO 2005035769A2 · 2005 [cited by applicant]
WO 2005041859A2 · 2005 [cited by applicant]
WO 2005042705A2 · 2005 [cited by applicant]
WO 2006068867A1 · 2006 [cited by applicant]
WO 2007019618A1 · 2007 [cited by applicant]
WO 2007070538A2 · 2007 [cited by applicant]
WO 2008112017A2 · 2008 [cited by applicant]
WO 2008115919A2 · 2008 [cited by applicant]
WO 2008141321A1 · 2008 [cited by applicant]
WO 2009014762A1 · 2009 [cited by applicant]
WO 2009024562A1 · 2009 [cited by applicant]
WO 2009151741A1 · 2009 [cited by applicant]
WO 2010056712A1 · 2010 [cited by applicant]
WO 2011097487A2 · 2011 [cited by applicant]
WO 2013004843A1 · 2013 [cited by applicant]
WO 2014064691A2 · 2014 [cited by applicant]
WO 2014159757A2 · 2014 [cited by applicant]
WO 2014188407A1 · 2014 [cited by applicant]
WO 2015001008A1 · 2015 [cited by applicant]
WO 2015197867A1 · 2015 [cited by applicant]
WO 2016140853A1 · 2016 [cited by applicant]
WO 2018023041A1 · 2018 [cited by applicant]
WO 2018038930A1 · 2018 [cited by applicant]
WO WO2018153943A1 · 2018 [cited by examiner]
WO 2019084038A1 · 2019 [cited by applicant]
WO 2019136462A1 · 2019 [cited by applicant]
WO 2019211314A1 · 2019 [cited by applicant]
WO 2020160613A1 · 2020 [cited by applicant]
WO 2020248067A1 · 2020 [cited by applicant]
WO 2021150522A1 · 2021 [cited by applicant]
WO 2022015941A1 · 2022 [cited by applicant]
WO 2022020314A1 · 2022 [cited by applicant]
Abrams et al., “Implantable Cranial Medical Device,” Cerebral Therapeutics, Inc., U.S. Appl. No. 63/052,284, filed Jul. 15, 2020, 77 pages. [cited by applicant]
Abrams et al., “Monitoring and Treatment Based on Continuous Intracranial EEG Activity,” Cerebral Therapeutics, Inc. U.S. Appl. No. 63/054,522, filed Jul. 21, 2020, 24 pages. [cited by applicant]
Abrams et al., “Treatment and Monitoring of Diseases Associated With Elevated Intracranial Pressure or Hydrocephalus,” Cerebral Therapeutics, Inc., U.S. Appl. No. 63/223,629, filed Jul. 20, 2021, 26 pages. [cited by applicant]
Abrams, Daniel, “Treatment and Monitoring of Post-Traumatic Stress Disorder,” Cerebral Therapeutics, Inc., U.S. Appl. No. 63/166,705, filed Mar. 26, 2021, 21 pages. [cited by applicant]
Abrams, Daniel, “Treatment and Monitoring of Post-Traumatic Stress Disorder,” Cerebral Therapeutics, Inc., U.S. Appl. No. 63/172,313, filed Apr. 8, 2021, 28 pages. [cited by applicant]
Written Opinion of the International Preliminary Examining Authority in PCT/US2021/042315, mailed Jun. 8, 2022, 8 pages. [cited by applicant]
International Preliminary Report on Patentability in PCT/US2021/042315, mailed Oct. 4, 2022, 22 pages. [cited by applicant]
International Search Report and Written Opinion in PCT/US2021/042315, mailed Oct. 8, 2021, 14 pages. [cited by applicant]
Stremlau et al., “The cytoplasmic body component TRIM5a restricts HIV-1 infection in Old World monkeys.” Nature 427.6977 (2004): 848-853. [cited by applicant]
Sugiyama et al., “RNA-dependent RNA polymerase is an essential component of a self-enforcing loop coupling heterochromatin assembly to siRNA production.” Proceedings of the National Academy of Sciences 102.1 (2005): 152… [cited by applicant]
Suh et al., “Human embryonic stem cells express a unique set of microRNAs.” Developmental biology 270.2 (2004): 488-498. [cited by applicant]
Sumimoto et al., “Gene therapy for human small-cell lung carcinoma by inactivation of Skp-2 with virally mediated RNA interference.” Gene therapy 12.1 (2005): 95-100. [cited by applicant]
Sun et al., “Development of a micro-array to detect human and mouse microRNAs and characterization of expression in human organs.” Nucleic acids research 32.22 (2004): e188-e188. [cited by applicant]
Sunkar et al., “Novel and stress-regulated microRNAs and other small RNAs from Arabidopsis.” The Plant Cell 16.8 (2004): 2001-2019. [cited by applicant]
Sussman et al., “Neuroanatomical features in soldiers with post-traumatic stress disorder.” BMC neuroscience 17.1 (2016): 1-11. [cited by applicant]
Suzuma et al., “Identification and characterization of novel small RNAs in the aspS-yrvM intergenic region of the Bacillus subtilis genome.” Microbiology 148.8 (2002): 2591-2598. [cited by applicant]
Svennerholm et al., “Alzheimer disease-effect of continuous intracerebroventricular treatment with GM1 ganglioside and a systematic activation programme.” Dementia and geriatric cognitive disorders 14.3 (2002): 128-136. [cited by applicant]
Swagerman et al., “The Computerized Neurocognitive Battery: Validation, aging effects, and heritability across cognitive domains.” Neuropsychology 30.1 (2016): 53-64. [cited by applicant]
Sygnus® Implantable Connector System, Balseal.com, Retrieved from the Internet: <URL: https://www.balseal.com/contact/sygnus/> (2024): 1-13. [cited by applicant]
Szymanski et al., “Noncoding RNA transcripts.” Journal of applied genetics 44.1 (2003): 1-20. [cited by applicant]
Tabara et al., “The dsRNA binding protein RDE-4 interacts with RDE-1, DCR-1, and a DExH-box helicase to direct RNAi in C. elegans.” Cell 109.7 (2002): 861-871. [cited by applicant]
Tabara et al., “The rde-1 gene, RNA interference, and transposon silencing in C. elegans.” Cell 99.2 (1999): 123-132. [cited by applicant]
Takamizawa et al., “Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival.” Cancer research 64.11 (2004): 3753-3756. [cited by applicant]
Tan et al., “RNAi, a new therapeutic strategy against viral infection.” Cell research 14.6 (2004): 460-466. [cited by applicant]
Tang et al., “A biochemical framework for RNA silencing in plants.” Genes & development 17.1 (2003): 49-63. [cited by applicant]
Tang,G. “siRNA and miRNA: an insight into RISCs.” Trends in biochemical sciences 30.2 (2005): 106-114. [cited by applicant]
Tanno et al., “Silencing of endogenous IGFBP-5 by micro RNA interference affects proliferation, apoptosis and differentiation of neuroblastoma cells.” Cell Death & Differentiation 12.3 (2005): 213-223. [cited by applicant]
Tanzer et al., “Evolution of microRNAs located within Hox gene clusters.” Journal of Experimental Zoology Part B: Molecular and Developmental Evolution 304.1 (2005): 75-85. [cited by applicant]
Tanzer et al., “Molecular evolution of a microRNA cluster.” Journal of molecular biology 339.2 (2004): 327-335. [cited by applicant]
Taylor et al., “The potential of RNA interference as a tool in the management of viral hepatitis.” Journal of hepatology 42.1 (2005): 139-144. [cited by applicant]
Teixeira et al., “Multiple numerical chromosome aberrations in cancer: what are their causes and what are their consequences.” Seminars in cancer biology. vol. 15. No. 1. Academic Press (2005): 3-12. [cited by applicant]
Teixeira et al., “Processing bodies require RNA for assembly and contain nontranslating mRNAs.” Rna 11.4 (2005): 371-382. [cited by applicant]
Thiagarajan, T. “EEG and FMRI Papers by the Numbers,” Sapien Labs, Retrieved from the Internet: <URL: https://sapienlabs.org/lab-talk/500000-human-neuroscience-papers/> (2016): 1-7. [cited by applicant]
Thomas et al., “Size constraints for targeting post-transcriptional gene silencing and for RNA-directed methylation in Nicotiana benthamiana using a potato virus X vector.” The Plant Journal 25.4 (2001): 417-425. [cited by applicant]
Thomson et al., “A custom microarray platform for analysis of microRNA gene expression.” Nature methods 1.1 (2004): 47-53. [cited by applicant]
Thurman et al., “Traumatic brain injury in the United States: a public health perspective.” The Journal of head trauma rehabilitation 14.6 (1999): 602-615. [cited by applicant]
Tijsterman et al., “Dicers at RISC: the mechanism of RNAi.” Cell 117.1 (2004): 1-3. [cited by applicant]
Tomari et al., “A protein sensor for siRNA asymmetry.” Science 306.5700 (2004): 1377-1380. [cited by applicant]
Tomari et al., “MicroRNA biogenesis: drosha can't cut it without a partner.” Current Biology 15.2 (2005): R61-R64. [cited by applicant]
Tomari et al., “Perspective: machines for RNAi.” Genes & development 19.5 (2005): 517-529. [cited by applicant]
Tops et al., “RDE-2 interacts with MUT-7 to mediate RNA interference in Caenorhabditis elegans.” Nucleic acids research 33.1 (2005): 347-355. [cited by applicant]
Trainor, P. “Developmental Biology Is “Cruzing”.” Developmental Cell 7.4 (2004): 481-486. [cited by applicant]
Trivedi et al., “The Inventory of Depressive Symptomatology, Clinician Rating (IDS-C) and Self-Report (IDS-SR), and the Quick Inventory of Depressive Symptomatology, Clinician Rating (QIDS-C) and Self-Report (QIDS-SR) i… [cited by applicant]
Trousselard et al., “Is plasma GABA level a biomarker of post-traumatic stress disorder (PTSD) severity? A preliminary study.” Psychiatry research 241 (2016): 273-279. [cited by applicant]
Tucker et al., “Efficacy and safety of topiramate monotherapy in civilian posttraumatic stress disorder: a randomized, double-blind, placebo-controlled study.” Journal of Clinical Psychiatry 68.2 (2007): 201-206. [cited by applicant]
Turner et al., “Review of recent methodological developments in group-randomized trials: part 1—design.” American journal of public health 107.6 (2017): 907-915. [cited by applicant]